Carbapenem-resistant Enterobacteriaceae among kidney transplant recipients - insights on the risk of acquisition and CRE infection

• Published in: Infectious diseases (London, England) Vol. 53; no. 6; pp. 430 - 439
• Main Authors: Freire, Maristela P., Carvalho, Laina B., Reusing, Jose Otto, Spadão, Fernanda, Lopes, Max Igor B. F., Nahas, William C., David-Neto, Elias, Pierrotti, Ligia C.
• Format: Journal Article
• Language: English
• Published: England Taylor & Francis 03.06.2021
• Subjects: Anti-Bacterial Agents - pharmacology; Anti-Bacterial Agents - therapeutic use; Carbapenem-Resistant Enterobacteriaceae; Carbapenems - pharmacology; Case-Control Studies; delay of graft function; diabetes nephropathy; Enterobacteriaceae Infections - drug therapy; Enterobacteriaceae Infections - epidemiology; Humans; Kidney Transplantation; lymphopenia; Polymyxin resistance; rejection; Risk Factors; Transplant Recipients; urinary tract infection; diabetes nephropathy; Polymyxin resistance; delay of graft function; lymphopenia; rejection; urinary tract infection

Kidney transplant recipients are a risk group for carbapenem-resistant Enterobacteriaceae infection. This study aimed to identify risk factors for CRE acquisition and infection among kidney transplant recipients. We conducted a case-control study; we defined the case as kidney transplant recipient w...